EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

EUDA Health Holdings LimitedNASDAQ: EUDA

Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026

Selling, general & admin grows, but more slowly than its trailing trend

Q2 FY2026 selling, general & admin of $1.02M rose 3.8% year over year, behind the +181.0% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -7.0% a year.

Context

  • Selling, general & admin amounted to 79.7% of revenue in FY2025, down 3.7 pp from a year earlier.
  • Selling, general & admin increased in 1 of the last 3 fiscal years.

What to watch

Whether selling, general & admin reaches the consensus estimate from 1 analysts of $27.86M (+412.9%) for the fiscal year ending Dec 2026, a step up from the +62.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.02M+0.0% QoQ
Last fiscal yearDec 2025
$5.43M+62.6% YoY
LTMJun 2026
$9.21M+181.0% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.8%+130.2%+126.4 pp
1 year+62.6%+412.9%+350.3 pp
3-year CAGR-7.0%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
5.43M USD
Year-over-year change
+62.6%
4-year CAGR
+31.6%
Reported Analyst consensus estimate

Selling, General & Admin vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +181.0% is the highest of 7, against a peer median of -8.1%.
  • Selling, general & admin amounts to 75.7% of revenue for EUDA, versus a peer median of 119.7%.
EUDA Competitors
Selling, General & Admin for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$120.99M USD-30.8%-16.8%51.0%
DTILPrecision BioSciences, Inc.LTM Mar 2026$30.49M USD-13.9%-7.9%67.6%
HYPRHyperfine, Inc.LTM Mar 2026$26.33M USD-2.2%-17.3%171.8%
FONRFONAR CorporationLTM Mar 2026$21.42M USD+168.1%—20.3%
ATYRaTyr Pharma, Inc.LTM Mar 2026$17.76M USD+24.8%+12.7%9346.3%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$17.25M USD—+15.2%—
EUDAEUDA Health Holdings LimitedLTM Jun 2026$9.21M USD+181.0%-7.0%75.7%
ZTEKZentek Ltd.LTM Mar 2026CA$5.32M CAD-33.6%-36.1%3202.5%
Peer median (excluding EUDA) —-8.1%-12.4%119.7%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.56M3.76M3.71M4.01M6.82M
Cost of Revenue3.31M2.89M2.86M3.25M3.83M
Gross Profit1.25M870K842.08K762.16K2.99M
Gross Margin27.4%23.1%22.7%19.0%43.9%
Research & Development129.27K17.21K00249
Selling, General & Admin1.81M6.75M4.8M3.34M5.43M
Operating Expenses1.81M13.09M4.8M18.1M5.43M
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
EBITDA1.34M(24.64M)(8.29M)(17.42M)(2.09M)
EBITDA Margin29.4%-654.6%-223.7%-434.4%-30.7%
Operating Income(559.99K)(5.72M)(3.96M)(17.34M)(2.44M)
Operating Margin-12.3%-151.9%-106.9%-432.2%-35.8%
Interest Income1.92M0000
Interest Expense127.13K93.78K23.23K44.89K228.62K
Other Income / Expenses2.23M(19.21M)(4.47M)(307.38K)(285.26K)
Income Before Tax1.67M(24.93M)(8.43M)(17.64M)(2.73M)
Pre-Tax Margin36.6%-662.3%-227.6%-439.8%-40.0%
Income Tax Expense46.49K(20.79K)0(4.38K)41.94K
Net Income864.83K(24.88M)(10.04M)(15.36M)(2.77M)
Net Margin19.0%-661.1%-270.9%-382.9%-40.7%
EPS (Basic)1.87(41.40)(8.80)(9.40)(1.49)
EPS (Diluted)1.87(41.40)(8.80)(9.40)(1.49)
Weighted Avg Shares462.67K601.48K1.15M1.62M1.86M
Weighted Avg Shares (Diluted)462.67K601.48K1.15M1.62M1.86M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.